WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- Investor RelationsAbout Us
- News & ResourcesAbout Us
WuXi XDC Reports Strong Business Updates with Superior Financial Results in 1H 2024: Poised for Future Growth
Revenue surged by 67.6% YoY to RMB 1,665 million Gross profit surged by 133.4% to RMB 535 million, with a gross profit margin of 32.1%, a 9.0 percentage points increase compared to 1H 2023. Net profit increased by 175.5% to RMB 488 million, with a net profit margin of...A Complex Play: The Essential Role of CMC in ADC Drug Development
Leon: Fantastic! Now I think everyone in the audience and around the world understands why we’ve invited three experts who definitely have many decades of experience in their respective fields, so let’s dive into it today. First, we will talk about how CMC...WuXi XDC Releases Inaugural ESG Report
Demonstrating Leadership in Sustainability and Innovation
SHANGHAI, May 29, 2024—WuXi XDC, a leading Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in antibody-drug conjugates (ADCs) and broader bioconjugates, announced the publication of its inaugural Environmental, Social, and...
WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones
Revenue reached RMB 2,124 million, an increase of 114% compared with Year 2022 Adjusted net profit reached RMB 412 million, an increase of 112% compared with Year 2022 Total number of integrated projects increased to 143 50 new integrated projects signed in 2023...WuXi XDC Announces Ground-breaking on Singapore Manufacturing Facility to Empower Global Bioconjugates Development
Shanghai, China, and Singapore, March 19, 2024—WuXi XDC (2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugates market, today announced a ground-breaking of manufacturing...
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?